Inventor · Palo Alto, CA, US

Ju Yang

53Patents
10h-index
42Co-inventors
74Inventor score

Filing activity: Dec 21, 2009 → Nov 29, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US8445515B2 C5aR antagonists Chemistry; Metallurgy 30 Active
US9126939B2 C5AR antagonists Chemistry; Metallurgy 27 Active
US8906938B2 C5aR antagonists Chemistry; Metallurgy 27 Active
US9573897B2 C5AR antagonists Chemistry; Metallurgy 24 Active
US10035768B2 C5aR antagonists Chemistry; Metallurgy 22 Active
US9834545B2 Modulators of chemokine receptors Chemistry; Metallurgy 22 Active
US9809581B2 Inhibitors of CXCR2 Chemistry; Metallurgy 20 Active
US10639284B2 Immunomodulator compounds Emerging Cross-Sectional Technologies 13 Active
US10919852B2 Immunomodulator compounds Emerging Cross-Sectional Technologies 12 Active
US10568874B2 Indane-amines as PD-L1 antagonists Emerging Cross-Sectional Technologies 11 Active
US11266643B2 Triaryl compounds for treatment of PD-L1 diseases Chemistry; Metallurgy 8 Active
US11135210B2 Indane-amines as PD-L1 antagonists Emerging Cross-Sectional Technologies 8 Active
US8835419B2 Substituted anilines as CCR(4) antagonists Chemistry; Metallurgy 7 Active
US11426364B2 Immunomodulator compounds Emerging Cross-Sectional Technologies 7 Active
US10370363B2 Inhibitors of CXCR2 Chemistry; Metallurgy 6 Active
US10336736B2 Modulators of chemokine receptors Chemistry; Metallurgy 6 Active
US9758512B2 Substituted anilines as CCR(4) antagonists Chemistry; Metallurgy 5 Active
US10660897B2 C5aR antagonists Chemistry; Metallurgy 5 Active
US9567323B2 Substituted anilines as CCR(4) antagonists Chemistry; Metallurgy 5 Active
US11485708B2 Compounds for treatment of PD-L1 diseases Emerging Cross-Sectional Technologies 4 Active
US9340509B2 CCR6 compounds Chemistry; Metallurgy 4 Active
US10988464B2 Modulators of chemokine receptors Chemistry; Metallurgy 3 Active
US11142521B2 Substituted anilines as CCR(4) antagonists Chemistry; Metallurgy 3 Active
US10421748B2 2-oxindole compounds Chemistry; Metallurgy 3 Active
US10407417B2 Substituted anilines as CCR(4) antagonists Chemistry; Metallurgy 3 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.